Abstract:IMPORTANCE: Globally, treatment-resistant depression affects approximately one-third of all patients diagnosed with major depressive disorder. Currently, there are neither behavioral nor neural measures that quantitatively phenotype characteristics underlying treatment-resistant depression. OBJECTIVE: Determine whether neurocomputational models that integrate information about adaptive behavior and associated self-reported feelings can characterize differences in patients with treatment-resistant depression. DESIGN: In this observational study, data were collected over two research visits from 2020-2023 that occurred before and after standard-of-care electroconvulsive therapy (ECT) for treatment-resistant depression. This report focuses on Visit 1, which occurred after patients consented to ECT but before their initial treatment. SETTING: Wake Forest University School of Medicine; Atrium Health Wake Forest Baptist Psychiatric Outpatient Center; Atrium Health Wake Forest Hospital. PARTICIPANTS: Participants planning to receive ECT for depression (pre-ECT) and participants not planning to receive ECT with (non-ECT) or without depression (no-depression), were recruited from the Psychiatric Outpatient Center and community. EXPOSURES: Computerized delivery of a Probabilistic Reward and Punishment with Subjective Rating task during fMRI. MAIN OUTCOMES AND MEASURES: Computational modeling of choice behavior provided parameters that characterized learning dynamics and associated affect dynamics expressed through intermittent Likert scale self-reports. Multivariate statistical analyses relating model parameters, neurobehavioral responses, and clinical assessments. RESULTS: Pre-ECT (N=29; 55.2% female), non-ECT (N=40; 70% female), and no-depression (N=41; 65.9% female). Parameters derived from computational models fit to behavior elicited during learning and the expression of affective experiences clearly differentiates the three groups. Reinforcement Learning model parameters alone do not perform as well as models that incorporate affective self-reports. Notably, the set of model parameters that include learning and affective dynamics demonstrated excellent, cross-validated, diagnostic classification of depression diagnosis. Prior to ECT, neurobehavioral responses associated with learning and affective experiences about "punishing" events were significantly impaired in pre-ECT compared to non-ECT and no-depression cohorts. CONCLUSIONS AND RELEVANCE: Computational models of behavioral dynamics associated with learning and affect can describe specific hypotheses about neurocomputational-mechanisms underlying treatment-resistant depression. The present work suggests differences in processing of emotionally negative states and suggests a potential model-based behavioral diagnostic for individuals with major depression. Such models may eventually be used to augment the diagnosis of treatment-resistant depression or possibly determine phenotype-genotype relationships for disease status and progression.

A computational model to characterize the time-course of response to rapid antidepressant therapies

Whole-brain turbulent dynamics predict responsiveness to pharmacological treatment in major depressive disorder

The pulvinar nucleus and antidepressant treatment: dynamic modeling of antidepressant response and remission with ultra-high field functional MRI

Response Trajectories During Escitalopram Treatment of Patients with Major Depressive Disorder

Optimizing Antidepressant Efficacy: Generalizable Multimodal Neuroimaging Biomarkers for Prediction of Treatment Response

Computational approaches to treatment response prediction in major depression using brain activity and behavioral data: A systematic review

Computational Phenotyping of Treatment-Resistant Depression prior to Electroconvulsive Therapy

Predictors of response to accelerated rTMS in the treatment of treatment-resistant depression

Antidepressant medications have evolved in terms of speed of onset of efficacy: How can we best measure antidepressant treatment response?

Predictive modeling of antidepressant efficacy based on cognitive neuropsychological theory

Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1

Computational Psychopharmacology: a Translational and Pragmatic Approach

Comparison of Two Methods for Determining Item Characteristic Functions and Latent Variable Time-Course for Pharmacometric Item Response Models

Prediction of antidepressant responses to non-invasive brain stimulation using frontal electroencephalogram signals: Cross-dataset comparisons and validation

Development of a model to predict antidepressant treatment response for depression among Veterans

Predicting Antidepressant Citalopram Treatment Response via Changes in Brain Functional Connectivity After Acute Intravenous Challenge

Multimodal workflows optimally predict response to repetitive transcranial magnetic stimulation in patients with schizophrenia: a multisite machine learning analysis

Depressive symptom trajectories associated with standard and accelerated rTMS

Modeling of cumulative effects of time-varying drug exposures on within-subject changes in a continuous outcome

Predicting Escitalopram Monotherapy Response in Depression: the Role of Anterior Cingulate Cortex

Connectome-based models can predict early symptom improvement in major depressive disorder